International Medical Research Frontier

Objective To explore the effective monitoring methods and effects of adverse drug reactions by drug regulatory authorities. Methods The research subjects of this study were 91 reported adverse drug reaction events, which were reported from October 2024 to October 2025. The organs, systems and types of drugs involved in the adverse reactions were analyzed. Results Regarding the sites of damage caused by adverse drug reactions, 38.46% were in the skin, 31.87% in the cardiovascular system, 9.89% in the immune system, and 8.79% in the nervous system. In terms of the types of drugs causing adverse reactions, 46.15% were antibiotics, 16.48% were traditional Chinese patent medicines, 9.89% were trace elements/ions, and 8.79% were expectorants. Conclusion Drug regulatory authorities need to formulate targeted management measures based on the deficiencies in adverse drug reaction monitoring to enhance the effectiveness of monitoring, thereby reducing adverse drug reactions and improving the safety of public medication.

Drug regulatory department; Adverse drug reactions; Antibiotic